Cargando…

The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction

The FGFR4-388Arg variant has been related to poor prognosis in several types of cancer, including lung cancer. The mechanism underlying this association has not been addressed in detail in patients with this pathology. Here, we report that this FGFR4 variant induces MAPK and STAT3 activation and cau...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quintanal-Villalonga, Álvaro, Ojeda-Márquez, Laura, Marrugal, Ángela, Yagüe, Patricia, Ponce-Aix, Santiago, Salinas, Ana, Carnero, Amancio, Ferrer, Irene, Molina-Pinelo, Sonia, Paz-Ares, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799167/ https://www.ncbi.nlm.nih.gov/pubmed/29402970 http://dx.doi.org/10.1038/s41598-018-20570-3

Ejemplares similares

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
por: Quintanal-Villalonga, Álvaro, et al.
Publicado: (2020)

Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry
por: Marrugal, Ángela, et al.
Publicado: (2019)

Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy
por: Marrugal, Ángela, et al.
Publicado: (2023)

MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma
por: Ferrer, Irene, et al.
Publicado: (2018)

Identification of Predictive Biomarkers of Response to HSP90 Inhibitors in Lung Adenocarcinoma
por: Marrugal, Ángela, et al.
Publicado: (2021)

Histology-dependent prognostic role of pERK and p53 protein levels in early-stage non-small cell lung cancer
por: Quintanal-Villalonga, Álvaro, et al.
Publicado: (2018)

Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications
por: Quintanal-Villalonga, A., et al.
Publicado: (2016)

Corrigendum to “Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications”
por: Quintanal-Villalonga, A., et al.
Publicado: (2018)

Corrigendum to “Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer”
por: Marrugal, Ángela, et al.
Publicado: (2018)

Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer
por: Marrugal, Ángela, et al.
Publicado: (2016)

FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients
por: Streit, S, et al.
Publicado: (2006)

FGFR4 GLY388ARG polymorphism modulates cancer patients' survival in pooled analysis
por: Frullanti, Elisa, et al.
Publicado: (2010)

Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer
por: Verdugo-Sivianes, Eva M., et al.
Publicado: (2017)

Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis
por: Matakidou, A, et al.
Publicado: (2007)

Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility
por: Chou, Chia-Hsuan, et al.
Publicado: (2017)

Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis
por: Xiong, Si-Wei, et al.
Publicado: (2017)

FGFR4 Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal Transition
por: Cho, Sang Hee, et al.
Publicado: (2017)

FGFR4 c.1162G > A (p.Gly388Arg) Polymorphism Analysis in Turkish Patients with Retinoblastoma
por: Akdeniz Odemis, Demet, et al.
Publicado: (2020)

Association between the miRNA Signatures in Plasma and Bronchoalveolar Fluid in Respiratory Pathologies
por: Molina-Pinelo, Sonia, et al.
Publicado: (2012)

FGFR4 Gly388Arg Polymorphism Reveals a Poor Prognosis, Especially in Asian Cancer Patients: A Meta-Analysis
por: Kim, Jung Han, et al.
Publicado: (2021)

FGFR4 Gly(388)Arg polymorphism contributes to prostate cancer development and progression: A meta-analysis of 2618 cases and 2305 controls
por: Xu, Bin, et al.
Publicado: (2011)

FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition
por: Ye, Yanwei, et al.
Publicado: (2020)

A rare case of highly differentiated follicular carcinoma in ovary with FGFR4 Gly388Arg polymorphism: a case report and literature review
por: Bao, Yi-Ting, et al.
Publicado: (2022)

Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer
por: Molina-Pinelo, Sonia, et al.
Publicado: (2016)

A Six-Gene Prognostic and Predictive Radiotherapy-Based Signature for Early and Locally Advanced Stages in Non-Small-Cell Lung Cancer
por: Peinado-Serrano, Javier, et al.
Publicado: (2022)

G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis
por: Jézéquel, P, et al.
Publicado: (2004)

The role of MMP-1 and FGFR4-R388 gene polymorphisms in pituitary adenoma
por: Zlatkutė, Eglė, et al.
Publicado: (2017)

Adrenal Corticomedullary Mixed Tumor Associated With the FGFR4-G388R Variant
por: Kanzawa, Maki, et al.
Publicado: (2020)

Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer
por: Peng, Tao, et al.
Publicado: (2021)

Distribution and activity of doxorubicin combined with SDZ PSC 833 in mice with P388 and P388/DOX leukaemia.
por: Colombo, T., et al.
Publicado: (1996)

Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas
por: Wimmer, Eva, et al.
Publicado: (2019)

Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer
por: Estevez-Garcia, Purificacion, et al.
Publicado: (2015)

The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy
por: Shim, Hyun-Jeong, et al.
Publicado: (2016)

MicroRNA-Dependent Regulation of Transcription in Non-Small Cell Lung Cancer
por: Molina-Pinelo, Sonia, et al.
Publicado: (2014)

A novel NPR2 mutation (p.Arg388Gln) in a patient with acromesomelic dysplasia, type Maroteaux
por: Amano, Naoko, et al.
Publicado: (2020)

Identification of Oxidative Stress Related Proteins as Biomarkers for Lung Cancer and Chronic Obstructive Pulmonary Disease in Bronchoalveolar Lavage
por: Pastor, Maria Dolores, et al.
Publicado: (2013)

Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy
por: García-Heredia, José M., et al.
Publicado: (2016)

PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome
por: Estevez-Garcia, Purificacion, et al.
Publicado: (2012)

Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer
por: Facchinetti, Francesco, et al.
Publicado: (2023)

E-Cadherin and FGFR1 Expression in Mouse Osteoblastogenesis in Normoxic Cultures
por: Al-Amer, Osama
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a520ito2ktf72g8a4ethfhu6t3